Blood News: Breaking Blood News, Comments and Articles.

IPO Preview: Bluebird Bio

By IPOdesktop: Based in Cambridge, MA, bluebird bio (BLUE) scheduled a $75 million IPO with a market capitalization of $314 million at a price range mid-point of $15, for Wednesday, June 19, 2013.Four other new IPOs are scheduled for the week of June 17th. The full IPO calendar is here. S-1 filed June 4, 2013 Manager, Joint Managers: J.P. Morgan; BofA Merrill Lynch Co Managers: Cowen; Canacc...

Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients

WHITE PLAINS, N.Y. , June 19, 2013 /- This year alone, The Leukemia & Lymphoma Society (LLS) is supporting more than 300 research projects with one goal in mind: Discovering lifesaving therapies for blood cancer patients. And in 2013, "Team...

New blood test detects colon cancer before it develops

DALLAS, June 19, 2013 /PRNewswire-USNewswire/ -- A new blood test developed in the Gastrointestinal Cancer Research Lab at Baylor Research Institute is showing very promising results for finding cancer-related microRNA in the blood before a tumor develops in the colon. (Photo: http://photos.prnewswire.com/prnh/20130619/DC33230) The test results, published in the latest issue of the Journa...

BoXin LaiTe Biotechnology and University of British Columbia Sign MOU

Sichuan BoXin LaiTe Biotechnology and its major shareholder, Heracles International Investment Inc. have signed a memorandum of understanding to form a partnership with the Center for Blood Research (CBR) at the University of British Columbia. BoXin...

GSMA: mHealth Grand Tour To Feature A First-of-its-Kind Live Diabetes Research Study

LONDON, June 19, 2013 /PRNewswire/ -- The GSMA today announced a first-of-its-kind clinical study for its mHealth Grand Tour in September 2013, which is designed to raise awareness of diabetes and promote the development and delivery of mHealth solutions in partnership with the International Diabetes Federation European Region (IDF Europe). The 13-day cycle ride will feature a live research study...

IPO Preview: Regado Biosciences

By IPOdesktop: Based in Basking Ridge, NJ, Regado Biosciences (RGDO) scheduled a $75 million IPO with a market capitalization of $219M at a price range mid-point of $15, for Wednesday, June 19, 2013.Four other new IPOs are scheduled for the week of June 17th. The full IPO calendar is here. S-1A filed May 29, 2013 Manager, Joint Managers: Cowen; BMO Capital Markets Co-Managers: C...

Equip Your Healthcare Center with the Most Innovative Medical Equipments from Zone Medical

Ormeau, Australia, June 19, 2013 --(PR.com)-- For all kinds of medical centers and healthcare establishments in Australia, it is the best time to buy medical equipments and all other kinds of consumable supplies as Zone Medical (www.zonemedical.com.au) has announced great offers on their supplies. Based in Australia, Zone Medical is a supplier of all kinds of medical diagnosing and surgery equipm...

Eylea can ease vision problems for wet AMD patients

There is no cure for age-related macular degeneration, an eye disease that is the leading cause of vision loss and blindness in older Americans. Last year, the National Institutes of Health reported that two drugs injected into the eyes, Avastin and...

Invivoscribe FLT3 Testing Patents Strengthened by Supreme Court Ruling

SAN DIEGO, CA -- (Marketwired) -- 06/19/13 -- In Association of Molecular Pathology v. Myriad, the U.S. Supreme Court struck down BRCA1 and BRCA2 gene patent claims. It is important for the diagnostic community to note that the limits of the Myriad decision applies only to patents on genes and portions of genes themselves, 'compositions of matter' that already exist in nature. In contrast, Invivo...

Certain Types Of Graft-Versus-Host Disease May Increase Risk Of Death

Joseph Pidala, M.D., M.S., assistant member of the Blood and Bone Marrow Transplant and Immunology programs at Moffitt Cancer Center, and colleagues from the Chronic Graft-Versus-Host Disease Consortium have determined that certain gastrointestinal a...

Mannitol May Prevent Aggregation Of Toxic Proteins In Parkinson's Disease

Mannitol, a sugar alcohol produced by fungi, bacteria, and algae, is a common component of sugar-free gum and candy. The sweetener is also used in the medical field - it's approved by the FDA as a diuretic to flush out excess fluids and used during s...

EMA issues warnings over codeine use

Children and young adults who have had surgery to remove their tonsils or adenoids to treat sleep apnoea should not receive codeine as pain relief, the European Medicines Agency has stated. The warning follows reports of serious adverse effects and...

Study shows probiotic Lactobacillus reuteri NCIMB 30242 significantly increased vitamin D levels

(FoodMinds LLC) A study published in the Journal of Clinical Endocrinology & Metabolism is the first report of an oral probiotic supplement significantly increasing circulating vitamin D levels in the blood.

First Golden Goose Award of 2013 goes to Wallace Coulter

(Association of American Universities) The first 2013 Golden Goose Award will be awarded to the late Wallace H. Coulter, a researcher and inventor who some fifty years ago turned research on paint for the Navy into the Coulter Counter, which remains...

Heart Failure And Hypertension Meds May Help Decrease Obesity

A type of drug normally used to treat heart failure and high blood pressure helped prevent weight gain and other complications related to a high-fat diet in an animal study. The results were presented at The Endocrine Society's 95th Annual Meeting in...

Immunity Mechanism Discovered by Scientists

Scientists at the University of Calgary's Faculty of Medicine have discovered a mechanism that is used to protect the body from harmful bacteria. Platelets, a component of blood typically associated with clotting, were discovered to actively search for specific bacteria, and upon detection, seal it off from the rest of the body. The findings,

Patients Lead The Way As Medicine Grapples With Apps

Christine Porter is hooked on the My Fitness Pal app. In October, after deciding to lose 50 pounds, Porter started typing in everything she eats, drinks and any exercise she gets. “This is like my main page here,” says Porter, who lost 42 pounds in nine months. “It’s telling me I have about 1,200 calories remaining for the day. When I want to record something I just click t...

Immunity mechanism discovered

Scientists at the University of Calgary's Faculty of Medicine have discovered a mechanism that is used to protect the body from harmful bacteria. Platelets, a component of blood typically associated with clotting, were discovered to actively search f...

Oxygen Biotherapeutics Reports Successful Completion of FDA Requested Immunocompetency Studies on Oxycyte®

Results from Safety Studies to be Submitted to FDA in July Oxygen Biotherapeutics, Inc. (“OBI”) (NASDAQ: OXBT), is a development stage biomedical company currently focused on developing its perfluorocarbon-based intravenous oxygen carrier, Oxycyte®, as a treatment for traumatic brain injury (TBI), stroke and other conditions where critical tissues...

Scientists Link Genetic Contributor To Heart Disease Risk

Lee Rannals for redOrbit.com – Your Universe Online Researchers from the University of Leicester have identified a potential genetic contributor that leads to an increased risk of heart disease in men. The team wrote in the journal Arteriosclerosis, Thrombosis, and Vascular Biology that men who carry a particular type of the Y chromosome have an increased risk. They also identified the possibl...

[Mast Therapeutics] nets $23.4mm through public offering

[Mast Therapeutics Inc.] (formerly AdventRx Pharmaceuticals; hematology and oncology therapies) netted $23.4mm through the public sale of 50mm units at $0.50 apiece. Each unit consisted of one common share and a five-year warrant to purchase half of...

[AMAG] to sell {MuGard} in the US for [Access Pharmaceuticals]

[AMAG Pharmaceuticals Inc.] (blood disorder therapy) has licensed exclusive US rights to the {MuGard} oral wound rinse in the US and its territories from [Access Pharmaceuticals Inc.] (supportive cancer care).

Index Ventures provides $11mm Series A financing to [XO1]

[XO1 Ltd.] (blood clotting antibodies) has raised $11mm in Series A financing from sole investor Index Ventures, via its $200mm Life Sciences Fund. The start-up will initially operate as a virtual entity and outsource drug development.

Doctors Confirm Fibromyalgia Is Not Imaginary

Lee Rannals for redOrbit.com – Your Universe Online Doctors have been able to determine the source of pain in the skin of patients who suffer from fibromyalgia. Fibromyalgia, a widespread deep tissue pain, affects about ten million people in the US. The condition causes tenderness in the hands and feet, fatigue, sleep disorders and cognitive decline. For years, the disorder was believed to be...

Inexpensive Blood Test Reveals HPV Presence, Potential Cancer Risk

Brett Smith for redOrbit.com – Your Universe Online Earlier this month, actor Michael Douglas raised the prospect of oral sex leading to throat cancer through the transmission of the human papillomavirus (HPV), a virus known to cause the disease in some individuals. According to a new study from a team of international researchers in the Journal of Clinical Oncology, blood tests can be used t...